霍奇金淋巴瘤斗篷放疗后乳房再造结局
该研究回顾性分析52例因霍奇金淋巴瘤接受斗篷放疗后行乳房切除术并即刻再造的患者,共97侧再造。两组总体并发症率无统计学差异,但自体组织再造的非计划修整率显著更高(OR 6.09)。
要点
- 斗篷放疗后即刻乳房再造总体安全,并发症谱可接受。
- 植入物再造与自体组织再造总体并发症率无显著差异。
- 自体组织再造非计划修整率约为植入物再造的6倍。
核心结论
- 斗篷放疗后即刻乳房再造采用植入物或自体技术均可安全完成,并发症谱可接受。
- 在本研究人群中,自体乳房再造与植入物再造相比非计划修整率更高。
研究设计与样本
- 回顾性研究,纳入2家机构10年期间因霍奇金淋巴瘤接受斗篷放疗后行乳房切除术并即刻再造的患者。
- 收集人口学、临床特征及结局(并发症与手术修整),行单因素和多因素分析比较两种再造方式。
主要发现
- 植入物再造组年龄大于自体组织再造组(47 ± 8.8岁 vs 42 ± 6.5岁,P < 0.05)。
- 植入物再造组平均随访时间短于自体组织再造组(5年 vs 8.3年;P < 0.05)。
- 两组从斗篷放疗到再造的间隔时间相近(23.4 ± 9年 vs 21.3 ± 6.1年,P = 0.6)。
- 总体并发症率在植入物再造组与自体组织再造组间无统计学差异(35% vs 16%,P = 0.16)。
- 自体组织再造组非计划修整率显著高于植入物再造组(比值比6.09;95%CI 1.14-32.48;P = 0.035)。
临床怎么用
- 对斗篷放疗后需乳房再造的患者,植入物与自体组织均可作为可选方案。
- 选择自体组织再造时应告知非计划修整风险可能更高。
局限性
- 回顾性研究设计。
- 自体组织再造样本量较小(18侧)。
- 植入物再造组随访时间较短。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: External beam radiation in the mantle field has been a mainstay of therapy for Hodgkin's lymphoma for decades. The incidence of breast cancer in patients treated with mantle radiation is known to be elevated. Few studies have examined outcomes of breast reconstruction in this high-risk group. The current study presents the largest series of immediate breast reconstruction in this population and aims to evaluate reconstructive outcomes and examine differences between implant-based and autologous reconstructions. METHODS: A retrospective review of records from a 10-year period at 2 institutions was undertaken. Patients treated with mantle radiation for Hodgkin's lymphoma who subsequently underwent mastectomy with immediate reconstruction were identified. Patient demographics, clinical characteristics, and outcomes including complications and operative revisions were gathered. Univariate and multivariate analyses were conducted to assess differences between implant-based and autologous reconstructions. RESULTS: A total of 97 breast reconstructions were performed in 52 patients. Seventy-nine reconstructions were implant-based, and 18 were autologous. Patients with implant-based reconstructions were older than autologous reconstructions (47 ± 8.8 years vs 42 ± 6.5 years, P < 0.05). Both groups had long-term follow-up; however, the mean follow-up duration was shorter in the implant-based compared with the autologous group (5 years vs 8.3 years; P < 0.05). Otherwise, the groups were similar with respect to BMI, medical comorbidities, oncologic diagnosis, and therapy. The interval between mantle radiation and reconstruction was comparable for implant-based and autologous groups (23.4 ± 9 years vs 21.3 ± 6.1 years, P = 0.6). The overall complication rate of breast reconstruction was not statistically different between the implant-based and autologous groups (35% vs 16%, P = 0.16). Three implant-based reconstructions (3.7%) required explantation. There were no complete flap losses in the autologous group. An associated 6-fold higher rate of unplanned revisions was observed with the autologous reconstruction group compared with the implant-based reconstruction group (odds ratio, 6.09; 95% confidence interval, 1.14-32.48; P = 0.035). CONCLUSIONS: In this study, long-term follow-up suggests immediate breast reconstruction in patients with prior mantle radiation can be achieved safely with an acceptable complication profile utilizing either implant-based or autologous techniques. Autologous breast reconstruction is linked with a higher rate of revisions compared with implant-based breast reconstruction in this study population.
引用
- Freniere B, Irwin T, Guldbrandsen G, et al. Outcomes Following Breast Reconstruction in Patients With Prior Mantle Radiation for Treatment of Hodgkin's Lymphoma. Ann Plast Surg. 2020. PMID: 31663939. doi:10.1097/SAP.0000000000002087
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。